FDA Brief

Company record

Acella Pharmaceuticals, LLC

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Acella Pharmaceuticals, LLC.

Recalls

ReportedClassFirmProduct and reason
May 13 Class II Acella Pharmaceuticals, LLC
Drug
NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16
Chemical contamination; presence of lead and lithium above specification